INOTIV INC (NOTV) Stock Fundamental Analysis

NASDAQ:NOTV • US45783Q1004

0.2707 USD
0 (-0.73%)
At close: Feb 27, 2026
0.264 USD
-0.01 (-2.48%)
After Hours: 2/27/2026, 5:20:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

Overall NOTV gets a fundamental rating of 2 out of 10. We evaluated NOTV against 58 industry peers in the Life Sciences Tools & Services industry. NOTV may be in some trouble as it scores bad on both profitability and health. NOTV is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • NOTV had negative earnings in the past year.
  • In the past year NOTV has reported a negative cash flow from operations.
  • In the past 5 years NOTV reported 4 times negative net income.
  • The reported operating cash flow has been mixed in the past 5 years: NOTV reported negative operating cash flow in multiple years.
NOTV Yearly Net Income VS EBIT VS OCF VS FCFNOTV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100M -200M -300M

1.2 Ratios

  • The Return On Assets of NOTV (-8.90%) is comparable to the rest of the industry.
  • Looking at the Return On Equity, with a value of -50.45%, NOTV is doing worse than 74.14% of the companies in the same industry.
Industry RankSector Rank
ROA -8.9%
ROE -50.45%
ROIC N/A
ROA(3y)-11.68%
ROA(5y)-13.33%
ROE(3y)-51.04%
ROE(5y)-47.25%
ROIC(3y)N/A
ROIC(5y)N/A
NOTV Yearly ROA, ROE, ROICNOTV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60 -80

1.3 Margins

  • Looking at the Gross Margin, with a value of 23.58%, NOTV is doing worse than 81.03% of the companies in the same industry.
  • In the last couple of years the Gross Margin of NOTV has declined.
  • The Profit Margin and Operating Margin are not available for NOTV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 23.58%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.34%
GM growth 5Y-4.75%
NOTV Yearly Profit, Operating, Gross MarginsNOTV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40 -60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • NOTV does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, NOTV has more shares outstanding
  • NOTV has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, NOTV has a worse debt to assets ratio.
NOTV Yearly Shares OutstandingNOTV Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
NOTV Yearly Total Debt VS Total AssetsNOTV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • Based on the Altman-Z score of -1.18, we must say that NOTV is in the distress zone and has some risk of bankruptcy.
  • NOTV's Altman-Z score of -1.18 is on the low side compared to the rest of the industry. NOTV is outperformed by 72.41% of its industry peers.
  • NOTV has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
  • NOTV has a Debt to Equity ratio of 0.04. This is in the better half of the industry: NOTV outperforms 65.52% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z -1.18
ROIC/WACCN/A
WACC7.84%
NOTV Yearly LT Debt VS Equity VS FCFNOTV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

  • NOTV has a Current Ratio of 0.35. This is a bad value and indicates that NOTV is not financially healthy enough and could expect problems in meeting its short term obligations.
  • NOTV has a Current ratio of 0.35. This is amonst the worse of the industry: NOTV underperforms 94.83% of its industry peers.
  • A Quick Ratio of 0.27 indicates that NOTV may have some problems paying its short term obligations.
  • NOTV's Quick ratio of 0.27 is on the low side compared to the rest of the industry. NOTV is outperformed by 94.83% of its industry peers.
Industry RankSector Rank
Current Ratio 0.35
Quick Ratio 0.27
NOTV Yearly Current Assets VS Current LiabilitesNOTV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • NOTV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 55.97%, which is quite impressive.
  • The Revenue has been growing slightly by 4.54% in the past year.
  • The Revenue has been growing by 53.35% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)55.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.63%
Revenue 1Y (TTM)4.54%
Revenue growth 3Y-2.16%
Revenue growth 5Y53.35%
Sales Q2Q%0.84%

3.2 Future

  • Based on estimates for the next years, NOTV will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.30% on average per year.
  • Based on estimates for the next years, NOTV will show a quite strong growth in Revenue. The Revenue will grow by 14.55% on average per year.
EPS Next Y8.11%
EPS Next 2Y10.3%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.73%
Revenue Next 2Y4.57%
Revenue Next 3Y18.59%
Revenue Next 5Y14.55%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
NOTV Yearly Revenue VS EstimatesNOTV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 200M 400M 600M 800M 1B
NOTV Yearly EPS VS EstimatesNOTV Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 -1 -2 -3 -4

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for NOTV. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NOTV. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NOTV Price Earnings VS Forward Price EarningsNOTV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

  • NOTV's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. NOTV is cheaper than 75.86% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 18.51
NOTV Per share dataNOTV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y10.3%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • NOTV does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

INOTIV INC

NASDAQ:NOTV (2/27/2026, 5:20:02 PM)

After market: 0.264 -0.01 (-2.48%)

0.2707

0 (-0.73%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-09
Earnings (Next)05-05
Inst Owners23.91%
Inst Owner Change-3.79%
Ins Owners9.63%
Ins Owner Change-3.55%
Market Cap9.31M
Revenue(TTM)513.02M
Net Income(TTM)-68.63M
Analysts82.5
Price Target4.93 (1721.2%)
Short Float %6.47%
Short Ratio4.4
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.82%
Min EPS beat(2)2.91%
Max EPS beat(2)46.72%
EPS beat(4)3
Avg EPS beat(4)19.11%
Min EPS beat(4)-5.26%
Max EPS beat(4)46.72%
EPS beat(8)5
Avg EPS beat(8)-15.76%
EPS beat(12)7
Avg EPS beat(12)-9.79%
EPS beat(16)11
Avg EPS beat(16)102.67%
Revenue beat(2)1
Avg Revenue beat(2)0.36%
Min Revenue beat(2)-0.13%
Max Revenue beat(2)0.84%
Revenue beat(4)1
Avg Revenue beat(4)-1.12%
Min Revenue beat(4)-3.54%
Max Revenue beat(4)0.84%
Revenue beat(8)2
Avg Revenue beat(8)-2.65%
Revenue beat(12)5
Avg Revenue beat(12)-0.61%
Revenue beat(16)8
Avg Revenue beat(16)2.26%
PT rev (1m)0%
PT rev (3m)-12.12%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-25.49%
EPS NY rev (1m)0%
EPS NY rev (3m)-11.11%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.44%
Revenue NY rev (1m)-1.14%
Revenue NY rev (3m)-0.92%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.02
P/FCF N/A
P/OCF N/A
P/B 0.07
P/tB N/A
EV/EBITDA 18.51
EPS(TTM)-2.03
EYN/A
EPS(NY)-1.74
Fwd EYN/A
FCF(TTM)-0.79
FCFYN/A
OCF(TTM)-0.3
OCFYN/A
SpS14.91
BVpS3.95
TBVpS-5.77
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -8.9%
ROE -50.45%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 23.58%
FCFM N/A
ROA(3y)-11.68%
ROA(5y)-13.33%
ROE(3y)-51.04%
ROE(5y)-47.25%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.34%
GM growth 5Y-4.75%
F-Score5
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA 0.26
Cap/Depr 29.71%
Cap/Sales 3.24%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.35
Quick Ratio 0.27
Altman-Z -1.18
F-Score5
WACC7.84%
ROIC/WACCN/A
Cap/Depr(3y)39.68%
Cap/Depr(5y)78.3%
Cap/Sales(3y)4.2%
Cap/Sales(5y)6.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)55.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.63%
EPS Next Y8.11%
EPS Next 2Y10.3%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.54%
Revenue growth 3Y-2.16%
Revenue growth 5Y53.35%
Sales Q2Q%0.84%
Revenue Next Year3.73%
Revenue Next 2Y4.57%
Revenue Next 3Y18.59%
Revenue Next 5Y14.55%
EBIT growth 1Y32.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year281.84%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y7.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-53.64%
OCF growth 3YN/A
OCF growth 5YN/A

INOTIV INC / NOTV FAQ

Can you provide the ChartMill fundamental rating for INOTIV INC?

ChartMill assigns a fundamental rating of 2 / 10 to NOTV.


What is the valuation status for NOTV stock?

ChartMill assigns a valuation rating of 1 / 10 to INOTIV INC (NOTV). This can be considered as Overvalued.


What is the profitability of NOTV stock?

INOTIV INC (NOTV) has a profitability rating of 1 / 10.


What is the expected EPS growth for INOTIV INC (NOTV) stock?

The Earnings per Share (EPS) of INOTIV INC (NOTV) is expected to grow by 8.11% in the next year.